Research Overview
Across the studies reviewed here, maltodextrin is most frequently studied as a functional excipient and carrier material in formulation science—especially for microencapsulation and powder production in food and nutraceutical contexts. Multiple studies evaluate maltodextrin alone or blended with other biopolymers (notably gum arabic, and in more complex systems chitosan/alginate) using spray drying or freeze drying to stabilize sensitive bioactives (e.g., propolis/plant extracts, eggplant peel phenolics, astaxanthin). A second, smaller cluster of work treats maltodextrin primarily as a comparator or experimental input in gut microbiome research (as a placebo in clinical trials of psyllium; as a fermentable additive in ex vivo batch cultures). Additional, more specialized applications include pharmaceutical materials reviews that position maltodextrin among starch-derived polymers used for microparticulate drug delivery, and a targeted antimicrobial nanoplatform leveraging bacterial maltodextrin transport pathways (via maltotriose functionalization) for infection-specific delivery.
The strongest evidence in these studies supports maltodextrin’s utility as a generally effective, process-compatible matrix for converting bioactive-rich liquids/emulsions into stable powders and microcapsules, often improving encapsulation efficiency, protecting antioxidant compounds, and enabling controlled/slow release—particularly when combined with complementary wall materials (e.g., gum arabic increasing encapsulation efficiency; chitosan/alginate layers plus maltodextrin achieving >90% encapsulation efficiency and improved in vitro bioaccessibility for astaxanthin). Evidence also indicates maltodextrin can measurably influence microbial fermentation outputs in vitro (e.g., increased acetate and propionate and reduced branched-chain fatty acids in batch cultures), but in the clinical context presented it is used mainly as an inert placebo comparator rather than a primary intervention, limiting conclusions about in vivo microbiome effects from these trials alone.
Key research gaps include (i) more standardized, head-to-head comparisons across maltodextrin dextrose equivalents, concentrations, and processing conditions to link formulation variables to stability, release kinetics, sensory/handling properties, and bioavailability outcomes; (ii) stronger translational evidence that encapsulation benefits observed in vitro or in simulated digestion reliably improve human absorption and clinical endpoints; and (iii) clearer characterization of maltodextrin’s direct effects on the human gut microbiome and metabolite profiles under realistic dietary exposures, since current evidence here is largely ex vivo or indirect (placebo use). For emerging biomedical targeting strategies that exploit maltodextrin transport pathways, additional work is needed on specificity across bacterial species, safety, resistance potential, and comparative effectiveness versus standard therapies in clinically relevant models.
1. What conditions has Maltodextrin been studied for?
-
As a placebo/control in human trials (not as the active treatment):
Constipation / gut transit and microbiome outcomes: psyllium vs placebo (maltodextrin) in healthy volunteers and constipated patients over 7 days.
Exercise performance in heat: taurine and/or caffeine vs placebo (maltodextrin) in a crossover trial measuring time-to-exhaustion.
Type 2 diabetes mellitus (T2DM): antioxidant/prebiotic supplement vs control (maltodextrin) for 60 days.
Cognitive performance (dietary nitrate/beetroot-related chewable supplement): placebo-controlled crossover trial used a placebo (abstract truncated; maltodextrin commonly used as placebo, but the provided text does not explicitly confirm it here).
-
Food/pharmaceutical technology applications (functional role as an excipient/carrier rather than a therapy):
Microencapsulation to protect bioactives: pink pepper + green propolis extracts; eggplant peel extract; sour cherry anthocyanins; astaxanthin microcapsules (improved stability, controlled release, and in vitro bioaccessibility).
Protein/antibody stabilization in dried foods: egg yolk powder processing where maltodextrin (with other excipients) reduced aggregation and improved solubility and IgY retention.
Drug delivery excipient: review notes maltodextrin/dextrins as commonly used carriers in microparticulate delivery systems.
-
Microbiome/fermentation effects (preclinical/ex vivo): batch fermentation of human fecal samples with maltodextrin as a food additive to assess microbiome composition and short-chain fatty acid (SCFA) production.
-
Infection targeting (biomedical engineering context): a bacterial keratitis nano-antibacterial system used a maltodextrin transport pathway for bacterial targeting via maltotriose modification (this is not dietary maltodextrin supplementation, but a biological targeting concept involving maltodextrin uptake systems).
2. Does it work in treating those conditions? Summarize the evidence.
-
No direct evidence in these studies that maltodextrin “treats” a medical condition. In the human clinical trials provided, maltodextrin primarily served as a placebo/control (constipation/psyllium trial; exercise taurine/caffeine trial; T2DM adjunct trial). Those studies test other interventions, not maltodextrin as the active agent.
-
Evidence for functional/technological efficacy (not disease treatment):
-
Improving stability/retention of sensitive compounds via encapsulation:
Eggplant peel extract powders: spray-drying with maltodextrin at 170°C produced powders with the highest total phenolic content and high antioxidant assay values (e.g., DPPH, ABTS) among carrier conditions tested.
Sour cherry anthocyanins: spray-dried powders with maltodextrin showed high encapsulation efficiency (>90%); stability testing over 28 days suggested light exposure did not reduce anthocyanin content when maltodextrin was used. Copigmentation + maltodextrin improved retention versus non-copigmented samples.
Astaxanthin microcapsules: maltodextrin-containing microcapsules achieved >90% encapsulation efficiency and increased in vitro bio-accessibility to 69 ± 1%, with slow release modulated by the capsule components.
Pink pepper + green propolis: maltodextrin used with gum arabic improved encapsulation efficiency; combined encapsulating agents increased DPPH inhibition by ~31% (suggesting better protection/preservation of antioxidant activity).
-
Improving properties of dried protein-rich foods: In egg yolk powder, adding excipients including maltodextrin inhibited freezing-induced aggregation and improved solubility and active IgY retention, especially with microwave-assisted freeze-drying.
-
-
Microbiome effects (supportive but not clinical treatment evidence): In an ex vivo fermentation model, maltodextrin increased acetate and propionate and decreased branched-chain fatty acids. This shows it can alter fermentation outputs, but it does not establish clinical benefit or harm in humans.
3. What health benefits does it have?
-
Indirect benefits as a formulation aid (best-supported by these studies):
May improve stability and delivery of bioactives (e.g., anthocyanins, astaxanthin, plant polyphenols) by acting as an encapsulating matrix in spray-dried/freeze-dried powders, often with high encapsulation efficiency (>90% reported in multiple studies) and improved retention/stability metrics.
May improve bioaccessibility of lipophilic compounds: astaxanthin microcapsules containing maltodextrin achieved 69 ± 1% in vitro bio-accessibility in simulated digestion.
May help preserve functional proteins during drying: in egg yolk powder processing, excipients including maltodextrin improved solubility and active IgY retention compared with conventional freeze-drying.
-
Potential gut fermentation effects (uncertain clinical significance): ex vivo, maltodextrin increased acetate and propionate production. Whether this translates into meaningful health outcomes in vivo depends on dose, context, and individual microbiome, and is not established by these studies.
-
Not demonstrated here: These studies do not show maltodextrin itself improving constipation, T2DM outcomes, or exercise performance; it was used as a placebo in those trials.
4. Does it have any downsides or side effects?
-
From the studies reviewed here, direct adverse effects in humans are not reported (likely because maltodextrin was used as a placebo/control and the studies shown do not describe placebo-related harms).
-
Potential downsides suggested by mechanistic/ex vivo data (not proof of clinical harm):
It can change microbial fermentation outputs: in batch cultures, maltodextrin increased acetate and propionate and decreased branched-chain fatty acids. This indicates biological activity in the gut environment, but the health implications are not resolved by this study design (ex vivo fermentation cannot capture whole-body physiology, dosing patterns, or long-term effects).
-
Evidence limitations: The studies reviewed here do not address common real-world concerns (e.g., glycemic impact, GI symptoms at higher intakes, or effects in diabetes) directly as outcomes attributable to maltodextrin; therefore, side-effect conclusions cannot be made from these texts alone.
5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?
No pharmacogenomic findings are provided in these studies for maltodextrin (i.e., no gene–maltodextrin interactions, genotype-stratified outcomes, or variant-specific safety/efficacy data).
What is discussed instead: maltodextrin appears mainly as an excipient (encapsulation matrix, stabilizer) or placebo, and one abstract references a bacterial maltodextrin transport pathway for targeting infection (a microbial targeting mechanism, not human pharmacogenomics).
Conclusion: Based on the studies reviewed here, there is insufficient evidence to claim maltodextrin is beneficial or harmful for any specific human genetic variation.
References
-
Microencapsulation of bioactive compound extracts using maltodextrin and gum arabic by spray and freeze-drying techniques.
Emanuele Joana Gbur Laureanti, Thainnane Silva Paiva, Luiz Mário de Matos Jorge, Regina Maria Matos Jorge (2023) - International journal of biological macromolecules -
Application of gum Arabic and maltodextrin for encapsulation of eggplant peel extract as a natural antioxidant and color source.
Khashayar Sarabandi, Seid Mahdi Jafari, Alireza Sadeghi Mahoonak, Adeleh Mohammadi (2019) - International journal of biological macromolecules -
The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls.
Jonna Jalanka, Giles Major, Kathryn Murray, Gulzar Singh, Adam Nowak, Caroline Kurtz, Inmaculada Silos-Santiago, Jeffrey M Johnston, Willem M de Vos, Robin Spiller (2019) - International journal of molecular sciences -
The impact of food additives, artificial sweeteners and domestic hygiene products on the human gut microbiome and its fibre fermentation capacity.
Konstantinos Gerasimidis, Katie Bryden, Xiufen Chen, Eleftheria Papachristou, Anais Verney, Marine Roig, Richard Hansen, Ben Nichols, Rodanthi Papadopoulou, Alison Parrett (2020) - European journal of nutrition -
Preparation and characterization of astaxanthin-loaded microcapsules stabilized by lecithin-chitosan-alginate interfaces with layer-by-layer assembly method.
Juan Huang, Shuo Zhang, Dongchen Liu, Xuan Feng, Qingding Wang, Shennan An, Mengting Xu, Lanling Chu (2024) - International journal of biological macromolecules -
Application of Starch, Cellulose, and Their Derivatives in the Development of Microparticle Drug-Delivery Systems.
Paolina Lukova, Plamen Katsarov, Bissera Pilicheva (2023) - Polymers -
Maltodextrin-driven MOF Nano-antibacterial system for effective targeted bacteria and enhancing photodynamic therapy in bacterial keratitis.
Lifang Chen, Yao Wang, Xiuqing Huang, Lifang Han, Zhengwei Huang, Ling Guo, Kai Chen, Guoxin Tan (2025) - Journal of controlled release : official journal of the Controlled Release Society -
Effects of Caffeine-Taurine Co-Ingestion on Endurance Cycling Performance in High Temperature and Humidity Environments.
Peiqi Yu, Yongzhao Fan, Hao Wu (2024) - Sports health -
Effect of maltodextrin and Persian gum as wall materials and tannic acid as copigment on some properties of encapsulated sour cherry anthocyanin microcapsules.
Niloofar Moshfegh, Mehrdad Niakousary, Seyed Mohammad Hashem Hosseini, Seyed Mohammad Mazloomi, Azam Abbasi (2025) - Food chemistry -
Improving effect of disaccharides and maltodextrin on preparation of egg yolk powder by microwave-assisted freeze-drying: Functional properties, structural properties, and retention rate of active IgY.
Zhe Wang, Xu Duan, Guangyue Ren, Jingfang Guo, Jiangtao Ji, Yiming Xu, Weiwei Cao, Linlin Li, Mengyue Zhao, Yuan Ang, Xin Jin, Bhesh Bhandari, Lewen Zhu, Yan Zhang (2023) - Food chemistry -
Sucrose, maltodextrin and inulin efficacy as cryoprotectant, preservative and prebiotic - towards a freeze dried
Sumbo Oluwatoyin Oluwatosin, Siew Leng Tai, Marijke Antonia Fagan-Endres (2022) - Biotechnology reports (Amsterdam, Netherlands) -
Diabetes Therapeutics of Prebiotic Soluble Dietary Fibre and Antioxidant Anthocyanin Supplement in Patients with Type 2 Diabetes: Randomised Placebo-Controlled Clinical Trial.
Chompoonut Teparak, Juntanee Uriyapongson, Jatuporn Phoemsapthawee, Orathai Tunkamnerdthai, Ploypailin Aneknan, Terdthai Tong-Un, Charnchai Panthongviriyakul, Naruemon Leelayuwat, Ahmad Alkhatib (2025) - Nutrients -
Acute effects of a chewable beetroot-based supplement on cognitive performance: a double-blind randomized placebo-controlled crossover clinical trial.
Maria Grazia Vaccaro, Bernardo Innocenti, Erika Cione, Luca Gallelli, Giovambattista De Sarro, Diego A Bonilla, Roberto Cannataro (2024) - European journal of nutrition -
Whey protein and maltodextrin-stabilized oil-in-water emulsions: Effects of dextrose equivalent.
Qiwei Du, Jinjing Tang, Mingjiang Xu, Fei Lyu, Jianyou Zhang, Yue Qiu, Jianhua Liu, Yuting Ding (2021) - Food chemistry -
Microencapsulation of Propolis and Honey Using Mixtures of Maltodextrin/Tara Gum and Modified Native Potato Starch/Tara Gum.
Carlos A Ligarda-Samanez, David Choque-Quispe, Elibet Moscoso-Moscoso, Mary L Huamán-Carrión, Betsy S Ramos-Pacheco, Germán De la Cruz, José C Arévalo-Quijano, Jenny C Muñoz-Saenz, Mauricio Muñoz-Melgarejo, Uriel R Quispe-Quezada, Edgar Gutiérrez-Gómez, Rober Luciano-Alipio, Miluska M Zamalloa-Puma, Genaro Julio Álvarez-López, Reynaldo Sucari-León (2023) - Foods (Basel, Switzerland) -
Effects of Creatine and Caffeine Supplementation During Resistance Training on Body Composition, Strength, Endurance, Rating of Perceived Exertion and Fatigue in Trained Young Adults.
Avery Pakulak, Darren G Candow, Julia Totosy de Zepetnek, Scott C Forbes, Daniele Basta (2022) - Journal of dietary supplements -
An "all-in-one" therapeutic platform for programmed antibiosis, immunoregulation and neuroangiogenesis to accelerate diabetic wound healing.
Yang Xue, Lan Zhang, Jun Chen, Dayan Ma, Yingang Zhang, Yong Han (2025) - Biomaterials -
L-arginine vs. L-glutamine oral suspensions for radiation-induced oral mucositis: a triple-blind randomized trial.
Fatma E A Hassanein, Christine Mikhail, Sarah Elkot, Asmaa Abou-Bakr (2025) - Journal of cancer research and clinical oncology -
Effect of beta-alanine, with and without sodium bicarbonate, on 2000-m rowing performance.
Ruth M Hobson, Roger C Harris, Dan Martin, Perry Smith, Ben Macklin, Bruno Gualano, Craig Sale (2013) - International journal of sport nutrition and exercise metabolism -
Fructose-Glucose Composite Carbohydrates and Endurance Performance: Critical Review and Future Perspectives.
David S Rowlands, S Houltham, K Musa-Veloso, F Brown, L Paulionis, D Bailey (2015) - Sports medicine (Auckland, N.Z.)
This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!